Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

China flag China · Delayed Price · Currency is CNY
10.82
-0.23 (-2.08%)
Jun 11, 2026, 2:05 PM CST
Market Cap3.20B -11.0%
Revenue (ttm)847.91M +4.3%
Net Income34.60M +20.5%
EPS0.12 +22.1%
Shares Out 289.15M
PE Ratio92.40
Forward PEn/a
Dividend0.10 (0.90%)
Ex-Dividend DateJun 11, 2026
Volume4,731,902
Open11.21
Previous Close11.05
Day's Range10.72 - 11.21
52-Week Range10.72 - 32.14
Beta0.39
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:002365

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China. [Read more]

Sector Healthcare
Founded 2001
Employees 912
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002365
Full Company Profile

Financial Performance

In 2025, SHE:002365's revenue was 783.17 million, a decrease of -6.63% compared to the previous year's 838.81 million. Earnings were 22.49 million, a decrease of -63.58%.

Financial Statements